Promoting evidence-based non-drug interventions: time for a non-pharmacopoeia?

Promoting evidence-based non-drug interventions: time for a non-pharmacopoeia?

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Glasziou, P
التنسيق:	Journal article
اللغة:	English
منشور في:	2009

مواد مشابهة

Pharmacopoeia boosts the fight against substandard drugs

The International pharmacopoeia /
حسب: World Health Organization
منشور في: (2006)

British Pharmacopoeia 2015
حسب: Medicines and Healthcare Products Regulatory Agency, وآخرون
منشور في: (2014)

British Pharmacopoeia 2019
حسب: Stationery Office (Great Britain)
منشور في: (2018)

British Pharmacopoeia 2012
حسب: Medicines and Healthcare Products Regulatory Agency, وآخرون
منشور في: (2011)

British pharmacopoeia 2011
حسب: Medicines and Healthcare Products Regulatory Agency
منشور في: (2010)

British pharmacopoeia 2014
حسب: Medicines and Healthcare Products Regulatory Agency, وآخرون
منشور في: (2013)

British pharmacopoeia 2013
حسب: Medicines and Healthcare Products Regulatory Agency, وآخرون
منشور في: (2012)

British Pharmacopoeia 2016
حسب: Stationery Office (Great Britain)
منشور في: (2015)

British Pharmacopoeia 2015
حسب: Medicines and Healthcare Products Regulatory Agency, وآخرون
منشور في: (2014)

British Pharmacopoeia 2017
حسب: Stationery Office (Great Britain)
منشور في: (2016)

British pharmacopoeia 2018
حسب: Stationery Office (Great Britain)
منشور في: (2017)

British pharmacopoeia 2011
حسب: Medicines and Healthcare Products Regulatory Agency, وآخرون
منشور في: (2010)

British Pharmacopoeia 2008/
حسب: Medicines and Healthcare Products Regulatory Agency
منشور في: (2007)

British Pharmacopoeia 1993
منشور في: (1993)

Lovewizard and God's pharmacopoeia
حسب: Carlos Lozano Quijada
منشور في: (2012-06-01)

The International Pharmacopoeia: Focus, Processes, Response to COVID-19 and Collaboration with other Pharmacopoeias
حسب: H. Schmidt, وآخرون
منشور في: (2023-06-01)

Comparison of the State Pharmacopoeia, XIII edition and the European Pharmacopoeia requirements for human plasma products
حسب: A. V. Karyakin, وآخرون
منشور في: (2018-02-01)

Single botanical drugs in the Ayurvedic Pharmacopoeia of India—A quantitative ethnobotanical analysis
حسب: Ruyu Yao, وآخرون
منشور في: (2023-05-01)

British Pharmacopoeia 2012 [electronic resource]
حسب: Medicines and Healthcare Products Regulatory Agency, وآخرون
منشور في: (2011)

British pharmacopoeia 2014 [electronic resource]
حسب: Medicines and Healthcare Products Regulatory Agency, وآخرون
منشور في: (2013)

British pharmacopoeia 2013 [electronic resource]
حسب: Medicines and Healthcare Products Regulatory Agency, وآخرون
منشور في: (2012)

American herbal pharmacopoeia : botanical pharmacognosy /
حسب: Upton, Roy
منشور في: (2011)

British Pharmacopoeia 1993 Addendum 1995
منشور في: (1995)

“Antidotarium ” of Nicholas of Salerno : the history of the pharmacopoeia
حسب: F. D. Voronov, وآخرون
منشور في: (2017-05-01)

The state pharmacopoeia in the system of higher education
حسب: I. I. Krasnyuk, وآخرون
منشور في: (2018-02-01)

The history of development of Pharmacopoeia standards quality biological drugs and methods of tests in Russia
حسب: T. M. Kargina, وآخرون
منشور في: (2018-02-01)

REGULATION OF DRUGS PRODUCTION IN RUSSIA XVI AND XVII CENTURIES: VINEYARD, PHARMACOPOEIAS, LECHEBNIK
حسب: Y. I. Zelikson
منشور في: (2019-01-01)

Military pharmacopoeias at the turn of the 19th century
حسب: Maria Turos
منشور في: (2019-12-01)

Pharmaceutical Substances. Requirements of the State Pharmacopoeia for Their Standardization
حسب: E. I. Sakanyan, وآخرون
منشور في: (2020-05-01)

Scientific aspects of the development of the State Pharmacopoeia of Ukraine
حسب: A. I. Gryzodub
منشور في: (2018-02-01)

Russian military pharmacopoeias in the military health system
حسب: Yu. V. Miroshnichenko, وآخرون
منشور في: (2018-02-01)

Ensuring the quality of medicines in India: An update on the development, modernization, and harmonization of drug standards in the Indian Pharmacopoeia
حسب: Gaurav Pratap Singh Jadaun, وآخرون
منشور في: (2023-12-01)

Repurposing of approved drugs from the human pharmacopoeia to target Wolbachia endosymbionts of onchocerciasis and lymphatic filariasis
حسب: Kelly L. Johnston, وآخرون
منشور في: (2014-12-01)

The Indian Pharmacopoeia Commission: Challenge, Compliance of Pharmaceutical Industries
حسب: Ritu Tiwari, وآخرون
منشور في: (2024-12-01)

PHARMACEUTICAL LEGISLATION: EUROPEAN PHARMACOPOEIA AND FORMULARIUM SLOVENICUM WITH SUPPLEMENTS
حسب: Martina Cvelbar, وآخرون
منشور في: (2003-01-01)

Comparison of the World Pharmacopoeias’ Requirements for the Quality of Cell Lines
حسب: M. A. Vodyakova, وآخرون
منشور في: (2020-09-01)

The History of the Creation of the VII State Pharmacopoeia of the USSR (Review)
حسب: K. S. Guzev
منشور في: (2021-05-01)

TABLETS. REGULATORY REQUIREMENTS OF THE STATE PHARMACOPOEIA XIII EDITION
حسب: N. V. Isaeva, وآخرون
منشور في: (2019-01-01)

The European Pharmacopoeia: bringing pharmaceutical standard harmonisation to Europe
حسب: Susanne Keitel
منشور في: (2018-02-01)